Table of Content

"1    INTRODUCTION    30
1.1    OBJECTIVES OF THE STUDY    30
1.2    MARKET DEFINITION    30
1.2.1    INCLUSIONS & EXCLUSIONS OF THE STUDY    31
1.3    MARKET SCOPE    31
1.3.1    MARKETS COVERED    31
1.3.2    YEARS CONSIDERED FOR THE STUDY    32
1.3.3    CURRENCY    32
1.4    STAKEHOLDERS    33
1.5    SUMMARY OF CHANGES    33
2    RESEARCH METHODOLOGY    35
2.1    RESEARCH APPROACH    35
2.2    RESEARCH METHODOLOGY DESIGN    35
FIGURE 1    PAIN MANAGEMENT DEVICES MARKET: RESEARCH DESIGN    35
2.2.1    SECONDARY RESEARCH    36
2.2.1.1    Key data from secondary sources    37
2.2.2    PRIMARY DATA    38
FIGURE 2    PRIMARY SOURCES    38
2.2.2.1    Key data from primary sources    39
2.2.2.2    Key industry insights    39
FIGURE 3    BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    40
FIGURE 4    BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS    40
2.3    MARKET SIZE ESTIMATION    41
FIGURE 5    SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS    41
FIGURE 6    REVENUE SHARE ANALYSIS ILLUSTRATION: MEDTRONIC PLC    42
FIGURE 7    REVENUE ANALYSIS OF THE TOP FIVE COMPANIES: PAIN MANAGEMENT DEVICES MARKET (2020)    43
FIGURE 8    CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE PAIN MANAGEMENT DEVICES MARKET (2021–2026)    45
FIGURE 9    CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS    45
FIGURE 10    TOP-DOWN APPROACH    46
2.4    MARKET BREAKDOWN & DATA TRIANGULATION    47
FIGURE 11    MARKET DATA TRIANGULATION METHODOLOGY    47
2.5    MARKET SHARE ANALYSIS    48
2.6    ASSUMPTIONS FOR THE STUDY    48
2.7    RISK ASSESSMENT    49
TABLE 1    RISK ASSESSMENT: PAIN MANAGEMENT DEVICES MARKET    49
2.8    LIMITATIONS    49
2.8.1    METHODOLOGY-RELATED LIMITATIONS    49
2.8.2    SCOPE-RELATED LIMITATIONS    49
3    EXECUTIVE SUMMARY    50
FIGURE 12    PAIN MANAGEMENT DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION)    50
FIGURE 13    NEUROSTIMULATION MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)    51
FIGURE 14    INFUSION PUMP MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)    51
FIGURE 15    ABLATION DEVICES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)    52
FIGURE 16    PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION,
2021 VS. 2026 (USD MILLION)    52
FIGURE 17    PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE,
2021 VS. 2026 (USD MILLION)    53
FIGURE 18    GEOGRAPHIC SNAPSHOT: INFUSION PUMPS MARKET    54
4    PREMIUM INSIGHTS    56
4.1    PAIN MANAGEMENT DEVICES MARKET OVERVIEW    56
FIGURE 19    GROWING DEMAND FOR LONG-TERM PAIN MANAGEMENT AMONG THE GERIATRIC POPULATION—PRIMARY MARKET DRIVER    56
4.2    ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET SHARE, BY APPLICATION & REGION (2020)    57
FIGURE 20    NEUROSTIMULATION TO HOLD THE LARGEST SHARE OF THE ASIA PACIFIC PAIN MANAGEMENT DEVICES MARKET IN 2020    57
4.3    PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC MIX    58
FIGURE 21    THE US TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD    58
4.4    REGIONAL MIX: PAIN MANAGEMENT DEVICES MARKET    59
FIGURE 22    NORTH AMERICA DOMINATED THE MARKET IN 2020    59
5    MARKET OVERVIEW    60
5.1    INTRODUCTION    60
5.2    MARKET DYNAMICS    60
FIGURE 23    PAIN MANAGEMENT DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    60
5.2.1    MARKET DRIVERS    61
5.2.1.1    Rising demand for chronic pain management in home care settings    61
5.2.1.2    Growing number of surgical procedures performed    61
5.2.1.3    Rising prevalence of neurological disorders    62
5.2.1.3.1    Growing incidence of sports injuries and cancer    62
TABLE 2    COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015–2019    63
5.2.1.4    Established reimbursement scenario for spinal cord stimulation (SCS) devices in developed countries    63
5.2.2    MARKET RESTRAINTS    64
5.2.2.1    Product recalls    64
5.2.2.2    High procedural and purchase cost of pain management devices    64
5.2.3    MARKET OPPORTUNITIES    65
5.2.3.1    High growth opportunities in emerging countries    65
TABLE 3    RISING INCOME LEVELS IN EMERGING COUNTRIES    65
5.2.3.2    Expanding base of pain management clinics/centers across the globe    66
5.2.3.3    Use of pain medications as the first line of treatment for pain management    66
5.2.3.4    Stringent regulatory guidelines delay the adoption of novel devices    67
TABLE 4    PRESENCE OF ALTERNATIVE THERAPIES FOR PAIN MANAGEMENT IS A MAJOR MARKET CHALLENGE    67
5.3    REGULATORY LANDSCAPE    68
TABLE 5    INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING PAIN MANAGEMENT DEVICES    68
5.3.1    NORTH AMERICA    69
5.3.1.1    US    69
TABLE 6    US FDA: MEDICAL DEVICE CLASSIFICATION    69
TABLE 7    US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS    69
FIGURE 24    PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES    70
5.3.1.2    Canada    70
FIGURE 25    CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES    71
5.3.2    EUROPE    72
FIGURE 26    EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES    73
5.3.3    ASIA PACIFIC    74
5.3.3.1    Japan    74
TABLE 9    JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)    74
5.3.3.2    China    74
TABLE 10    CHINA: CLASSIFICATION OF MEDICAL DEVICES    75
5.3.3.3    India    76
FIGURE 27    LATIN AMERICA: REGULATORY SCENARIO    77
5.3.3.4    Brazil    77
FIGURE 28    BRAZIL: REGULATORY PROCESS FOR MEDICAL DEVICES    78
TABLE 11    BRAZIL: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS    78
5.3.3.5    Mexico    79
FIGURE 29    MEXICO: REGULATORY PROCESS FOR MEDICAL DEVICES    79
TABLE 12    MEXICO: TIME, COST, AND COMPLEXITY OF THE REGISTRATION PROCESS    80
5.4    VALUE CHAIN ANALYSIS    80
FIGURE 30    PAIN MANAGEMENT DEVICES MARKET: VALUE CHAIN ANALYSIS    81
5.5    SUPPLY CHAIN ANALYSIS    81
FIGURE 31    PAIN MANAGEMENT DEVICES MARKET: SUPPLY CHAIN ANALYSIS    82
5.6    PORTER’S FIVE FORCES ANALYSIS    83
TABLE 13    PORTER’S FIVE FORCES ANALYSIS    83
5.6.1    THREAT FROM NEW ENTRANTS    84
5.6.2    THREAT FROM SUBSTITUTES    84
5.6.3    BARGAINING POWER OF SUPPLIERS    84
5.6.4    BARGAINING POWER OF BUYERS    85
5.6.5    COMPETITIVE RIVALRY    85
5.7    INDUSTRY TRENDS    85
5.7.1    WEARABLE DEVICES    85
5.7.2    RISING POPULARITY OF RECHARGEABLE SPINAL CORD STIMULATORS    85
5.8    TRADE ANALYSIS    86
5.8.1    TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES    86
TABLE 14    IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY,
2016–2020 (USD BILLION)    86
5.9    COVID-19 IMPACT ON THE PAIN MANAGEMENT DEVICES MARKET    86
6    PAIN MANAGEMENT DEVICES MARKET, BY TYPE    88
6.1    INTRODUCTION    89
TABLE 15    PAIN MANAGEMENT DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)    89
6.2    NEUROSTIMULATION DEVICES    89
TABLE 16    NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    90
TABLE 17    NEUROSTIMULATION DEVICES MARKET, BY REGION,
2019–2026 (USD MILLION)    90
6.2.1    TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) DEVICES    90
6.2.1.1    Extensive use in healthcare, low cost, and ease of use will favor market growth    90
TABLE 18    TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)    91
6.2.2    SPINAL CORD STIMULATION    91
6.2.2.1    Rising incidence of indications and efficacy & reversibility of procedure have supported the adoption of SCS    91
TABLE 19    SPINAL CORD STIMULATION DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)    92
6.3    INFUSION PUMPS    92
6.3.1    HIGH USE OF INFUSION PUMPS IN POSTOPERATIVE PAIN MANAGEMENT    92
TABLE 20    INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    93
TABLE 21    INFUSION PUMPS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)    93
6.3.2    INTRATHECAL INFUSION PUMPS    93
TABLE 22    INTRATHECAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)    94
6.3.3    EXTERNAL INFUSION PUMPS    94
TABLE 23    EXTERNAL INFUSION PUMPS DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)    95
6.4    ABLATION DEVICES    95
TABLE 24    ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    95
TABLE 25    ABLATION DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)    96
6.4.1    RF ABLATION DEVICES    96
TABLE 26    RF ABLATION DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)    97
6.4.2    CRYOABLATION DEVICES    97
TABLE 27    CRYOABLATION DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)    98
7    PAIN MANAGEMENT DEVICES MARKET, BY APPLICATION    99
7.1    INTRODUCTION    100
TABLE 28    PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)    100
7.2    NEUROPATHIC PAIN    100
7.2.1    HIGH PREVALENCE OF DISEASES ASSOCIATED WITH NEUROPATHIC PAIN    100
TABLE 29    NEUROPATHIC PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)    101
7.3    CANCER PAIN    101
TABLE 30    CANCER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)    102
7.4    FACIAL PAIN & MIGRAINE    102
TABLE 31    FACIAL PAIN & MIGRAINE MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)    104
7.5    MUSCULOSKELETAL PAIN    104
TABLE 32    MUSCULOSKELETAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2019–2026 (USD MILLION)    105
7.6    OTHER APPLICATIONS    105
TABLE 33    OTHER PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)    106
8    PAIN MANAGEMENT DEVICES MARKET, BY MODE OF PURCHASE    107
8.1    INTRODUCTION    108
TABLE 34    PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE,
2019–2026 (USD MILLION)    108
8.2    OVER-THE-COUNTER PAIN MANAGEMENT DEVICES    108
8.2.1    OTC PAIN MANAGEMENT DEVICES UNFOLD NEW GROWTH AVENUES    108
TABLE 35    OVER-THE-COUNTER PAIN MANAGEMENT DEVICES MARKET SIZE,
BY REGION, 2019–2026 (USD MILLION)    109
8.3    PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES    109
TABLE 36    PRESCRIPTION-BASED PAIN MANAGEMENT DEVICES MARKET SIZE,
BY REGION, 2019–2026 (USD MILLION)    110

9    PAIN MANAGEMENT DEVICES MARKET, BY REGION    111
9.1    INTRODUCTION    112
FIGURE 32    PAIN MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES    112
TABLE 37    GLOBAL PAIN MANAGEMENT DEVICES MARKET SIZE, BY REGION,
2019–2026 (USD MILLION)    113
9.2    NORTH AMERICA    113
FIGURE 33    NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT    114
TABLE 38    NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)    114
TABLE 39    NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    115
TABLE 40    NORTH AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    115
TABLE 41    NORTH AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    115
TABLE 42    NORTH AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    116
TABLE 43    NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION)    116
TABLE 44    NORTH AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    116
9.2.1    THE US    117
9.2.1.1    The US is expected to hold the leading position in the market due to the rising geriatric population, increasing prevalence of chronic diseases, and the growing home healthcare market    117
TABLE 45    KEY MACROINDICATORS FOR THE US    117
TABLE 46    US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    118
TABLE 47    US: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    118
TABLE 48    US: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    118
TABLE 49    US: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    119
TABLE 50    US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)    119
TABLE 51    US: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    119
9.2.2    CANADA    120
9.2.2.1    Increasing incidence of chronic pain indications to support the adoption of pain management devices in Canada    120
TABLE 52    KEY MACROINDICATORS FOR CANADA    120
TABLE 53    CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    121
TABLE 54    CANADA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    121
TABLE 55    CANADA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    121
TABLE 56    CANADA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    122
TABLE 57    CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)    122
TABLE 58    CANADA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    122
9.3    EUROPE    123
TABLE 59    EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION)    124
TABLE 60    EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    124
TABLE 61    EUROPE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    125
TABLE 62    EUROPE: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    125
TABLE 63    EUROPE: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    125
TABLE 64    EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)    126
TABLE 65    EUROPE: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    126
9.3.1    GERMANY    126
9.3.1.1    Presence of leading pain management device manufacturers to drive market growth in Germany    126
TABLE 66    KEY MACROINDICATORS FOR GERMANY    127
TABLE 67    GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    128
TABLE 68    GERMANY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    128
TABLE 69    GERMANY: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    128
TABLE 70    GERMANY: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    129
TABLE 71    GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)    129
TABLE 72    GERMANY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    129
9.3.2    FRANCE    130
TABLE 73    KEY MACROINDICATORS FOR FRANCE    130
TABLE 74    FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    131
TABLE 75    FRANCE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    131
TABLE 76    FRANCE: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    131
TABLE 77    FRANCE: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    132
TABLE 78    FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)    132
TABLE 79    FRANCE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    132
9.3.3    THE UK    133
9.3.3.1    High burden of chronic pain in the country to propel the
growth of the pain management devices market    133
TABLE 80    KEY MACROINDICATORS FOR THE UK    134
TABLE 81    UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    134
TABLE 82    UK: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    134
TABLE 83    UK: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    135
TABLE 84    UK: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    135
TABLE 85    UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)    135
TABLE 86    UK: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    136
9.3.4    ITALY    136
9.3.4.1    Growing demand for cost-effective home care services to support market growth    136
TABLE 87    KEY MACROINDICATORS FOR ITALY    136
TABLE 88    ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
 2019–2026 (USD MILLION)    137
TABLE 89    ITALY: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    137
TABLE 90    ITALY: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    138
TABLE 91    ITALY: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    138
TABLE 92    ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)    138
TABLE 93    ITALY: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    139
9.3.5    SPAIN    139
9.3.5.1    Rising prevalence of cancer to support the market for pain management devices market in Spain    139
TABLE 94    KEY MACROINDICATORS FOR SPAIN    140
TABLE 95    SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    140
TABLE 96    SPAIN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    140
TABLE 97    SPAIN: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    141
TABLE 98    SPAIN: ABLATION DEVICES MARKET SIZE, BY TYPE,
 2019–2026 (USD MILLION)    141
TABLE 99    SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)    141
TABLE 100    SPAIN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    142
9.3.6    REST OF EUROPE    142
TABLE 101    ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    143
TABLE 102    ROE: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    143
TABLE 103    ROE: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    143
TABLE 104    ROE: ABLATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    144
TABLE 105    ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)    144
TABLE 106    ROE: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    144
9.4    ASIA PACIFIC    145
FIGURE 34    ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SNAPSHOT    146
TABLE 107    ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION)    147
TABLE 108    ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    147
TABLE 109    ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    147
TABLE 110    ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    148
TABLE 111    ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    148
TABLE 112    ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION, 2019–2026 (USD MILLION)    148
TABLE 113    ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    149
9.4.1    JAPAN    149
9.4.1.1    Large geriatric population in the country is driving the demand for infusion pumps    149
TABLE 114    KEY MACRO INDICATORS FOR JAPAN    150
TABLE 115    JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    150
TABLE 116    JAPAN: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    150
TABLE 117    JAPAN: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    151
TABLE 118    JAPAN: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    151
TABLE 119    JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)    151
TABLE 120    JAPAN: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    152
9.4.2    CHINA    152
9.4.2.1    Growing investments in healthcare infrastructure development in the country to drive market growth in China    152
TABLE 121    KEY MACRO INDICATORS FOR CHINA    153
TABLE 122    CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    153
TABLE 123    CHINA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    153
TABLE 124    CHINA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    154
TABLE 125    CHINA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    154
TABLE 126    CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)    154
TABLE 127    CHINA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    155
9.4.3    INDIA    155
9.4.3.1    High prevalence of lifestyle diseases in the country to drive the market for pain management devices market    155
TABLE 128    KEY MACRO INDICATORS FOR INDIA    156
TABLE 129    INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    156
TABLE 130    INDIA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    156
TABLE 131    INDIA: INFUSION PUMPS MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    157
TABLE 132    INDIA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    157
TABLE 133    INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY APPLICATION,
2019–2026 (USD MILLION)    157
TABLE 134    INDIA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    158
9.4.4    REST OF ASIA PACIFIC    158
9.4.4.1    High prevalence of chronic diseases in the region to drive the market for pain management devices    158
FIGURE 35    PREVALENCE OF DIABETES IN SOUTHEAST ASIA (2018/2019)    159
TABLE 135    ESTIMATED NUMBER OF CANCER CASES IN SOUTHEAST ASIAN COUNTRIES, 2020 VS. 2040 (IN THOUSAND)    159
FIGURE 36    HEALTHCARE EXPENDITURE (% GDP) IN SOUTHEAST ASIA (2018)    159
FIGURE 37    GERIATRIC POPULATION IN 2019 (% OF TOTAL POPULATION)    160
TABLE 136    REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    160
TABLE 137    REST OF ASIA PACIFIC: NEUROSTIMULATION DEVICES MARKET SIZE,
BY TYPE, 2019–2026 (USD MILLION)    160
TABLE 138    REST OF ASIA PACIFIC: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    161
TABLE 139    REST OF ASIA PACIFIC: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    161
TABLE 140    REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION)    161
TABLE 141    REST OF ASIA PACIFIC: PAIN MANAGEMENT DEVICES MARKET SIZE,
 BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    162
9.5    LATIN AMERICA    162
TABLE 142    LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    163
TABLE 143    LATIN AMERICA: NEUROSTIMULATION DEVICES MARKET SIZE, BY TYPE, 2019–2026 (USD MILLION)    163
TABLE 144    LATIN AMERICA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    163
TABLE 145    LATIN AMERICA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    164
TABLE 146    LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION)    164
TABLE 147    LATIN AMERICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    164
9.6    MIDDLE EAST AND AFRICA    165
9.6.1    IMPROVING HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH    165
TABLE 148    MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
 BY TYPE, 2019–2026 (USD MILLION)    165
TABLE 149    MIDDLE EAST & AFRICA: NEUROSTIMULATION DEVICES MARKET SIZE,
 BY TYPE, 2019–2026 (USD MILLION)    166
TABLE 150    MIDDLE EAST & AFRICA: INFUSION PUMPS MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    166
TABLE 151    MIDDLE EAST & AFRICA: ABLATION DEVICES MARKET SIZE, BY TYPE,
2019–2026 (USD MILLION)    166
TABLE 152    MIDDLE EAST AND AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY APPLICATION, 2019–2026 (USD MILLION)    167
TABLE 153    MIDDLE EAST & AFRICA: PAIN MANAGEMENT DEVICES MARKET SIZE,
BY MODE OF PURCHASE, 2019–2026 (USD MILLION)    167
10    COMPETITIVE LANDSCAPE    168
10.1    OVERVIEW    168
FIGURE 38    KEY DEVELOPMENTS OF PROMINENT PLAYERS OPERATING IN PAIN MANAGEMENT DEVICES MARKET (2020-2021)    169
10.2    REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS    170
FIGURE 39    REVENUE ANALYSIS OF THE TOP PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET    170
10.3    MARKET SHARE ANALYSIS    170
FIGURE 40    PAIN MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2020    171
10.4    COMPANY EVALUATION QUADRANT    172
10.4.1    STARS    172
10.4.2    EMERGING LEADERS    172
10.4.3    PERVASIVE PLAYERS    172
10.4.4    PARTICIPANTS    173
FIGURE 41    PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT (2020)    173
10.5    COMPANY EVALUATION QUADRANT FOR START-UPS    174
10.5.1    PROGRESSIVE COMPANIES    174
10.5.2    DYNAMIC COMPANIES    174
10.5.3    STARTING BLOCKS    174
10.5.4    RESPONSIVE COMPANIES    174
FIGURE 42    PAIN MANAGEMENT DEVICES MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS (2020)    175
10.6    COMPANY PRODUCT FOOTPRINT    176
TABLE 154    PRODUCT PORTFOLIO ANALYSIS: PAIN MANAGEMENT DEVICES MARKET    176
10.7    GEOGRAPHIC FOOTPRINT OF THE MAJOR PLAYERS IN THE PAIN MANAGEMENT DEVICES MARKET    177
TABLE 155    GEOGRAPHIC REVENUE MIX: PAIN MANAGEMENT DEVICES MARKET (2020)    177
10.8    COMPETITIVE SCENARIO    178
10.8.1    PRODUCT LAUNCHES    178
TABLE 156    PRODUCT LAUNCHES (JANUARY 2018 – JUNE 2021)    178
10.8.2    DEALS    181
TABLE 157    DEALS (JANUARY 2018–JUNE 2021)    181
10.8.3    OTHER DEVELOPMENTS    183
TABLE 158    OTHER DEVELOPMENTS (JANUARY 2018– JUNE 2021)    183
11    COMPANY PROFILES    184
11.1    KEY PLAYERS    184
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1    MEDTRONIC    184
TABLE 159    MEDTRONIC PLC: BUSINESS OVERVIEW    184
FIGURE 43    MEDTRONIC PLC: COMPANY SNAPSHOT (2020)    185
11.1.2    ABBOTT LABORATORIES    188
TABLE 160    ABBOTT LABORATORIES: BUSINESS OVERVIEW    188
FIGURE 44    ABBOTT LABORATORIES: COMPANY SNAPSHOT    188
TABLE 161    ABBOTT LABORATORIES: PRODUCT OFFERINGS    189
11.1.3    BOSTON SCIENTIFIC CORPORATION    191
TABLE 162    BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW    191
FIGURE 45    BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT    192
TABLE 163    BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS    193
11.1.4    STRYKER CORPORATION    195
TABLE 164    STRYKER: BUSINESS OVERVIEW    195
FIGURE 46    STRYKER CORPORATION: COMPANY SNAPSHOT    196
TABLE 165    STRYKER: PRODUCT OFFERINGS    196
11.1.5    BECTON, DICKINSON AND COMPANY    198
TABLE 166    BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW    198
FIGURE 47    BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)    199
11.1.6    B. BRAUN MELSUNGEN AG    202
TABLE 167    B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW    202
FIGURE 48    B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020)    203
11.1.7    BAXTER INTERNATIONAL INC.    207
TABLE 168    BAXTER INTERNATIONAL INC.: BUSINESS OVERVIEW    207
FIGURE 49    BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2020)    208
11.1.8    AVANOS MEDICAL, INC.    211
TABLE 169    AVANOS MEDICAL, INC.: BUSINESS OVERVIEW    211
FIGURE 50    AVANOS MEDICAL, INC.: COMPANY SNAPSHOT (2020)    212
11.1.9    TELEFLEX, INC.    214
TABLE 170    TELEFLEX, INC.: BUSINESS OVERVIEW    214
FIGURE 51    TELEFLEX, INC.: COMPANY SNAPSHOT (2020)    215
11.1.10    SMITHS MEDICAL    216
TABLE 171    SMITHS MEDICAL: BUSINESS OVERVIEW    216
FIGURE 52    SMITHS MEDICAL: COMPANY SNAPSHOT (2020)    217
11.1.11    NIPRO CORPORATION    219
TABLE 172    NIPRO CORPORATION: BUSINESS OVERVIEW    219
FIGURE 53    NIPRO CORPORATION: COMPANY SNAPSHOT (2019)    220
11.1.12    MOOG INC.    222
TABLE 173    MOOG INC.: BUSINESS OVERVIEW    222
FIGURE 54    MOOG INC.: COMPANY SNAPSHOT (2020)    223
11.1.13    ATRICURE    225
TABLE 174    ATRICURE: BUSINESS OVERVIEW    225
FIGURE 55    ATRICURE: COMPANY SNAPSHOT    225
TABLE 175    ATRICURE: PRODUCT OFFERINGS    226
11.1.14    NEVRO CORP.    227
TABLE 176    NEVRO CORP: BUSINESS OVERVIEW    227
FIGURE 56    NEVRO CORP.: COMPANY SNAPSHOT    227
TABLE 177    NEVRO CORP: PRODUCT OFFERINGS    228
11.1.15    MICREL MEDICAL DEVICES SA    229
TABLE 178    MICREL MEDICAL DEVICES SA: BUSINESS OVERVIEW    229
11.1.16    MINDRAY MEDICAL INTERNATIONAL LIMITED    231
TABLE 179    MINDRAY MEDICAL INTERNATIONAL LIMITED: BUSINESS OVERVIEW    231
11.1.17    SHENZHEN MEDRENA BIOTECH CO., LTD.    233
TABLE 180    SHENZHEN MEDRENA BIOTECH CO., LTD.: BUSINESS OVERVIEW    233
11.1.18    EPIC MEDICAL    234
TABLE 181    EPIC MEDICAL: BUSINESS OVERVIEW    234
11.1.19    BIONESS    235
11.1.20    SOTERIX MEDICAL    236
11.2    OTHER PLAYERS    237
11.2.1    INFUTRONIX SOLUTIONS LLC    237
TABLE 182    INFUTRONIX SOLUTIONS LLC: BUSINESS OVERVIEW    237
11.2.2    GIMER MEDICAL    239
11.2.3    BLUEWIND MEDICAL    239
11.2.4    NEURONANO    239
11.2.5    MICROTRANSPONDER    240
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12    APPENDIX    241
12.1    DISCUSSION GUIDE    241
12.2    KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL    245
12.3    AVAILABLE CUSTOMIZATIONS    247
12.4    RELATED REPORTS    248
12.5    AUTHOR DETAILS    249"